AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

DUKEMOUNT CAPITAL PLC

Share Issue/Capital Change May 5, 2020

4974_rns_2020-05-05_2d0611ba-31d4-42d8-b166-0442627610ab.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9993L

Dukemount Capital PLC

05 May 2020

Dukemount Capital PLC

05 May 2020      

05 May 2020

Dukemount Capital Plc

("Dukemount" or "the Company")

Admission To Trading For Placing Shares

It was previously announced on 22 April 2020 that the Company had raised, in aggregate, £255,034.50 before expenses, by way of a placing of 72,867,000 new ordinary shares (the "Placing Shares") at a price of 0.35 pence per share.

Admission to trading for these Placing shares is now expected to be on 6 May 2020.

Following Admission, the Company will have 439,033,666 ordinary shares in issue, none of which will be held in treasury. Accordingly, the total number of voting rights in the Company will be 439,033,666 and shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a  change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information, please visit www.dukemountcapitalplc.com or contact:

Dukemount Capital Plc Via St Swithins PR
Geoffrey Dart
St Swithins PR (Media and Investor Enquiries) Tel: +44 (0) 1732 521132
Gary Middleton [email protected]
Peterhouse Capital  Limited Tel: +44 (0) 207 469 0930
Lucy Williams/Duncan Vasey

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IOEBDGDUGDGDGGU

Talk to a Data Expert

Have a question? We'll get back to you promptly.